Flecainide-induced QRS complex widening correlates with negative inotropy

Pulmonary Delivery of Antiarrhythmic Drugs for Rapid Conversion of New-Onset Atrial Fibrillation

(2020) Richard L. Verrier et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Multimodal mechanisms and enhanced efficiency of atrial fibrillation cardioversion by pulmonary delivery of a novel flecainide formulation

(2019) Fernanda Tessarolo Silva et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Clinical effectiveness of a systematic “pill-in-the-pocket” approach for the management of paroxysmal atrial fibrillation

(2018) Jason G. Andrade et al.   HEART RHYTHM

Accelerated conversion of atrial fibrillation to normal sinus rhythm by pulmonary delivery of flecainide acetate in a porcine model

(2018) Richard L. Verrier et al.   HEART RHYTHM

Optimizing flecainide plasma concentration profile for atrial fibrillation conversion while minimizing adverse ventricular effects by rapid, low-dose intratracheal or intravenous administration

(2018) Alexandre A. Marum et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Pulmonary delivery of flecainide causes a rate-dependent predominant effect on atrial compared with ventricular depolarization duration revealed by intracardiac recordings in an intact porcine model

(2018) Victor Z. de Antonio et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Global epidemiology of atrial fibrillation

(2014) Faisal Rahman et al.   Nature Reviews Cardiology

Electrophysiological and Hemodynamic Effects of Vernakalant and Flecainide During Cardiac Resynchronization in Dyssynchronous Canine Hearts

(2013) Lars B. van Middendorp et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Pharmacokinetic–pharmacodynamic modeling of QRS-prolongation by flecainide: Heart rate-dependent effects during sinus rhythm in conscious telemetered dogs

(2013) Johan Sällström et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

(2011) Valentin Fuster et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

(2010) E. Aliot et al.   EUROPACE

Intravenous administration of flecainide or propafenone in patients with recent-onset atrial fibrillation does not predict adverse effects during 'pill-in-the-pocket' treatment

(2010) P. Alboni et al.   HEART